{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-077866","form_type":"8-K","ticker":"CTSO","cik":"0001175151","company_name":"Cytosorbents Corp","filed_at":"2024-07-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.344827+00:00","generated_at":"2026-05-31T23:16:55.025539+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"CytoSorbents secures $20M credit facility with Avenue Capital; $10M available at close","bullets":["Initial tranche $15M with $10M immediately available; $5M released upon FDA acceptance of DrugSorb-ATR De Novo.","Interest rate Prime + 5% (floor 13.5%); maturity July 2027 (extendable to Jan 2028 if full tranche drawn).","Lenders receive warrants for 1,645,569 shares and conversion option on up to $2M principal at 120% of closing price.","Proceeds to fund CytoSorb global commercialization, DrugSorb-ATR FDA/Health Canada submissions, and refinance Bridge Bank debt.","Trailing 12-month CytoSorb sales $32.2M as of March 31, 2024; DrugSorb-ATR TAM in US/Canada >$0.5B if approved."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-077866","json":"https://secwatch.observer/filing/0001104659-24-077866.json","markdown":"https://secwatch.observer/filing/0001104659-24-077866.md","text":"https://secwatch.observer/filing/0001104659-24-077866.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1175151/000110465924077866/0001104659-24-077866-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1175151/000110465924077866/tm2418904d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:16:55.025539+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}